Contract facts
FederalNo full NAICS 325412 intel page yet. Browse NAICS intelligence
Eo 14398 503A Pharmaceutical Drug Compounding Services is a federal award for 256-Network Contract Office 16 (36C256) held by Optum Infusion Services 308, LLC. Estimated value $300K ($300K obligated). Current period of performance ends Sep 30, 2027. Place of performance: CHANDLER AZ.
Eo 14398 503a pharmaceutical drug compounding services
Recompete timing
PublicCurrent PoP ends Sep 30, 2027 (348 days remaining). Agencies typically plan 12–18 months ahead — at 11.4 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 36C25627N0017? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordOptum Infusion Services 308, LLC — $3.6M obligated across 17 awards (firm-wide, all agencies).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C25627N0017?
36C25627N0017 (Eo 14398 503a pharmaceutical drug compounding) is a 256-Network Contract Office 16 (36C256) award with a potential value of $300K, currently held by Optum Infusion Services 308, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C256-27-N-0017?
36C256-27-N-0017 is the dashed form of PIID 36C25627N0017 (Eo 14398 503a pharmaceutical drug compounding), held by Optum Infusion Services 308, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C25627N0017?
256-Network Contract Office 16 (36C256) awarded 36C25627N0017 to Optum Infusion Services 308, LLC (potential $300K).
Who is the incumbent on 36C25627N0017?
Optum Infusion Services 308, LLC is the incumbent with $3.6M across 17 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2027.
When does Optum Infusion Services 308, LLC’s 36C25627N0017 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 36C25627N0017? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.